Last month, Microbiome Movement returned to Boston for its 8th Drug Development summit. With 2023’s multiple regulatory approvals for C. difficile microbiome treatments, the event set out to platform microbial-based […]
Introduction Last month, Biose industrie had the privilege of speaking at Microbiome Connect: Asia. The two-day congress took place in Seoul, Korea, and was attended by microbiome enthusiasts across academia […]
Aurillac, France, May 29th, 2023 Biose Industrie, a contract development manufacturing organisation (CDMO) and a world-leader of live biotherapeutic product (LBP) process development and production, and SBT instruments, a […]
Biose Industries takes pride in showcasing its partners and drawing attention to the fantastic work they are doing. We sat down with Alveolus Bio with whom we are working to […]
The Pharmabiotics Conference & Partnering returned for 2023, bringing together cutting-edge microbiome researchers and drug developers. In the heart of Lyon 220 microbiome stakeholders gathered to explore key topics facing […]
Access the Presentation Slides Here
Aurillac, France, March 2nd, 2023 Biose Industrie, a contract development manufacturing organisation (CDMO) and a world-leader of live biotherapeutic product (LBP) process development and production, announced today their plan […]
L-GAM and the French State through the “French Tech Souveraineté” scheme have signed a purchase agreement with the aim of acquiring joint control of Biose Industrie, a world leader in […]
Introduction Kisaco Research’s flagship Microbiome Connect event returned to Boston in November. Joined by a range of microbiome companies and researchers, the event covered both the R&D and manufacturing considerations […]